Target intelligence / Profile preview

Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC1S1)

Target
BLOC1S1
Molecular classification
Organelle biogenesis complex subunit, Protein acetyltransferase, Lysosomal/endosomal system adaptor, Cytoskeletal adaptor (interacts with actin and microtubule regulators)
01

Overview

Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC1S1; also known as BLOS1, GCN5L1, BORCS1) is a ubiquitously expressed protein that functions as an essential component of the BLOC-1 and BORC multiprotein complexes, which are required for the proper biogenesis, trafficking, and positioning of lysosome-related organelles such as melanosomes and platelet dense granules. BLOC1S1 contributes to membrane protein cargo trafficking within the endosomal-lysosomal system, interacts with cytoskeletal adaptors (e.g., αTAT1, RanBP2, WHAMM), and modulates both actin and microtubule-dependent dynamics to influence organelle positioning and tubular lysosome formation. It also acts as a protein acetyltransferase in mitochondria, affecting mitochondrial enzyme acetylation, energy metabolism, and cell stress responses. Knockout and disruption studies in animal models show BLOC1S1 is essential for processes such as lysosome reformation, synaptic vesicle trafficking, pigmentation, and survival, implicating its dysfunction in various organelle biogenesis and trafficking disorders. There is no evidence that BLOC1S1 is a direct therapeutic target or interacts with drugs.

Other names
BLOS1GCN5L1BORCS1RT14MICOAGCN5-like protein 1Protein RT14Protein acetyltransferase BLOC1S1GCN5 (general control of amino-acid synthesis, yeast, homolog)-like 1BLOC-1 subunit 1BORC subunit 1MTA1-interacting coactivator
02

Biological functions

Lysosome-related organelle biogenesisEndosomal sorting and traffickingRegulation of microtubule and actin cytoskeletonMitochondrial protein acetylationCellular stress response (e.g., ER stress adaptation)Organelle positioning (lysosomes, synaptic vesicles)
03

Disease associations

Neurodegenerative disease (lysosomal and synaptic dysfunction implied in animal models)Pigmentation defects (via melanosome biogenesis deficits)Platelet function disorders (dense granule biogenesis)Other (organelle trafficking disorders; associated with embryonic lethality in knockout mice)
04

Safety considerations

Disruption leads to impaired lysosome reformation and traffickingEmbryonic lethality in knockout mouse modelsNo direct safety data for drug targeting; not known as a drug target

Beyond the preview

Go deeper on Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC1S1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC1S1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call